Methods and compositions for treating and preventing disease associated with alphaVbeta5 integrin

Details for Australian Patent Application No. 2005229015 (hide)

Owner The Regents of the University of California

Inventors Atakilit, Amha; Sheppard, Dean

Agent Spruson & Ferguson

Pub. Number AU-B-2005229015

PCT Pub. Number WO2005/094391

Priority 60/559,175 02.04.04 US

Filing date 30 March 2005

Wipo publication date 13 October 2005

Acceptance publication date 30 August 2012

International Classifications

C07K 16/28 Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 Medicinal preparations containing antigens or antibodies - Antibodies

C12N 5/20 Undifferentiated human, animal or plant cells, e.g. cell lines - one of the fusion partners being a B lymphocyte

G01N 33/53 Investigating or analysing materials by specific methods not covered by groups - Immunoassay

Event Publications

2 November 2006 PCT application entered the National Phase

  PCT publication WO2005/094391 Priority application(s): WO2005/094391

30 August 2012 Application Accepted

  Published as AU-B-2005229015

27 September 2012 Application for Amendment

  The nature of the amendment is as shown in the statement(s) filed 06 Sep 2012 . Address for service in Australia - Spruson & Ferguson Level 35 St Martins Tower 31 Market Street Sydney NSW 2000

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005229019-A catheter steering device

2005229011-Methods and apparatus providing suction-assisted tissue engagement